This systematic review found chest imaging abnormalities persist in patients ≥3 months after COVID-19. The prevalence of imaging abnormalities is significantly related to the proportion of patients with dyspnoea, despite normal lung function measurements. Read the pick of the week.
No comments:
Post a Comment